Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Are you def? Read this sentence pls.
View:
Post by alleyesonme on Jun 19, 2024 4:48pm

Are you def? Read this sentence pls.

According to Jazz’s filings, in October 2023, it settled with Padagis US LLC and granted Padagis a license to manufacture, market, and sell its generic version of Epidiolex on a date that depends on the occurrence of certain other events. However, the settlement wasn’t with the remaining litigants.
 
Comment by mdjbrown on Jun 19, 2024 9:57pm
alleyesonme, just to throw a wrench into theories, there have been further developments regarding litigation settlement with defendants according to Jazz's Form Q10 filed for the quarterly period ended March 31, 2024 Epidiolex Patent Litigation "On October 24, 2023, we entered into a settlement agreement with Padagis US LLC, or Padagis, that resolved our patent litigation with Padagis ...more  
Comment by QContinuum1 on Jun 20, 2024 7:14am
First things first, deaf and illiterate are two very different things.  For the record, I am neither. Secondly, this settlement (and like others) has nothing to do with LABS, for had it, they would have had a ticker tape parade.  The silence is deafening. But one thing these settlements (thanks mjd) confirms is that LABS has partnered with Apotex.  So now we must wait until Apotex ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities